For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of GT Biopharma Inc (NASDAQ: GTBP) closed at $0.85 in the last session, up 4.97% from day before closing price of $0.81. In other words, the price has increased by $4.97 from its previous closing price. On the day, 1.53 million shares were traded. GTBP stock price reached its highest trading level at $0.8458 during the session, while it also had its lowest trading level at $0.787.
Ratios:
We take a closer look at GTBP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.70 and its Current Ratio is at 2.70. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, ROTH MKM on December 02, 2024, initiated with a Buy rating and assigned the stock a target price of $11.
On May 24, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
On April 13, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.B. Riley Securities initiated its Buy rating on April 13, 2021, with a $21 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTBP now has a Market Capitalization of 8987534 and an Enterprise Value of 6460534.
Stock Price History:
The Beta on a monthly basis for GTBP is 1.18, which has changed by -0.72019863 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, GTBP has reached a high of $3.85, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 21.58%, while the 200-Day Moving Average is calculated to be -49.00%.
Shares Statistics:
According to the various share statistics, GTBP traded on average about 2.34M shares per day over the past 3-months and 2178880 shares per day over the past 10 days. A total of 10.64M shares are outstanding, with a floating share count of 9.26M. Insiders hold about 12.92% of the company’s shares, while institutions hold 4.93% stake in the company. Shares short for GTBP as of 1765756800 were 1453242 with a Short Ratio of 0.62, compared to 1763078400 on 1427430. Therefore, it implies a Short% of Shares Outstanding of 1453242 and a Short% of Float of 13.719999999999999.
Earnings Estimates
GT Biopharma Inc (GTBP) is presently subject to a detailed evaluation by 1.0 analysts, each offering their unique perspectives on its market standing.
Analysts are recommending an EPS of between -$1.66 and -$1.66 for the fiscal current year, implying an average EPS of -$1.66. EPS for the following year is -$0.7, with 1.0 analysts recommending between -$0.7 and -$0.7.
